Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Meijerink, Martijn R
INJECTABL-II, NCT06630624: Dose Finding, Efficacy and Immunological Response of IP-001 Following RFA, MWA or IRE for CRLM	Recruiting	1/2	140	Europe	IP-001	M.R. Meijerink, Immunophotonics, Inc., Angiodynamics, Inc.	Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer	08/29	08/31